Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $504,000 | $100M | -99.50% |
Operating Income | $-140.59M | $-64.49M | -118.01% |
Net Income | $-116.59M | $-53.06M | -119.71% |
EPS (Basic) | $-1.43 | $-0.67 | -113.43% |
EPS (Diluted) | $-1.43 | $-0.67 | -113.43% |
R&D Expense | $76.17M | $99.94M | -23.78% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $2.44B | $2.24B | +8.67% |
Current Assets | $2.12B | $1.91B | +11.09% |
Total Liabilities | $355.08M | $389.47M | -8.83% |
Current Liabilities | $118.99M | $146.79M | -18.94% |
Stockholders' Equity | $2.08B | $1.85B | +12.35% |
Cash & Equivalents | $707.43M | $344.41M | +105.40% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $109.75M | $8.8M | +1147.32% |
Investing Cash Flow | $-97.8M | $117.83M | -183.00% |
Financing Cash Flow | $305.93M | $5.4M | +5561.25% |
D&A | $4.83M | $5.05M | -4.32% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -27894.2% | -64.5% | -27829.76% |
Net Margin | -23133.1% | — | — |
ROE | -5.6% | — | — |
ROA | -4.8% | — | — |
Current Ratio | $17.813 | — | — |
Debt to Equity | $0.17 | — | — |
Other companies in Biotechnology